These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Pyrazinoindolone inhibitors of MAPKAP-K2. Goldberg DR; Choi Y; Cogan D; Corson M; DeLeon R; Gao A; Gruenbaum L; Hao MH; Joseph D; Kashem MA; Miller C; Moss N; Netherton MR; Pargellis CP; Pelletier J; Sellati R; Skow D; Torcellini C; Tseng YC; Wang J; Wasti R; Werneburg B; Wu JP; Xiong Z Bioorg Med Chem Lett; 2008 Feb; 18(3):938-41. PubMed ID: 18221871 [TBL] [Abstract][Full Text] [Related]
13. Pyrazolo[4,3-c]quinolines, synthesis and specific inhibition of benzodiazepine receptor binding. Note II. Savini L; Massarelli P; Corti P; Pellerano C; Bruni G; Romeo MR Farmaco; 1993 Dec; 48(12):1675-86. PubMed ID: 8135991 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of 2-(N-arylcarboxamide)-3-substituted ethoxyindoles and their monoamine oxidase inhibitory and anticonvulsant activities. Gupta AK; Dwivedi C; Gupta TK; Parmar SS; Harbison RD J Pharm Sci; 1975 Jun; 64(6):1001-5. PubMed ID: 1133715 [TBL] [Abstract][Full Text] [Related]
15. Monoamine oxidase isoform-dependent tautomeric influence in the recognition of 3,5-diaryl pyrazole inhibitors. Chimenti F; Fioravanti R; Bolasco A; Manna F; Chimenti P; Secci D; Befani O; Turini P; Ortuso F; Alcaro S J Med Chem; 2007 Feb; 50(3):425-8. PubMed ID: 17266193 [TBL] [Abstract][Full Text] [Related]
16. Anticonvulsant activity and monoamine oxidase inhibitory properties of substituted 1,2,4-triazoles. Jaiswal RK; Parmar SS; Kumar S; James EC Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):499-502. PubMed ID: 7178660 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors. Reddy MV; Billa VK; Pallela VR; Mallireddigari MR; Boominathan R; Gabriel JL; Reddy EP Bioorg Med Chem; 2008 Apr; 16(7):3907-16. PubMed ID: 18272371 [TBL] [Abstract][Full Text] [Related]
18. 1-N-substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: synthesis and evaluation as MAO inhibitors. Gökhan N; Yeşilada A; Uçar G; Erol K; Bilgin AA Arch Pharm (Weinheim); 2003 Aug; 336(8):362-71. PubMed ID: 14502756 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and 5-HT3 affinity of new 3-substituted indoles at central nervous system. Monge A; Palop JA; Orts L; Oset C; Lasheras B Drug Des Discov; 1996 Oct; 14(2):157-70. PubMed ID: 9010621 [TBL] [Abstract][Full Text] [Related]
20. Novel 3,5-diaryl pyrazolines as human acyl-CoA:cholesterol acyltransferase inhibitors. Jeong TS; Kim KS; An S; Cho KH; Lee S; Lee WS Bioorg Med Chem Lett; 2004 Jun; 14(11):2715-7. PubMed ID: 15125920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]